Liver Diseases in South Korea: A Pulse Check of the Public's Knowledge, Awareness, and Behaviors
- PMID: 36444544
- PMCID: PMC9760893
- DOI: 10.3349/ymj.2022.0332
Liver Diseases in South Korea: A Pulse Check of the Public's Knowledge, Awareness, and Behaviors
Abstract
Purpose: National surveys in Korea have spotlighted suboptimal levels of awareness among the public towards liver-related health and diseases, leading to progressive reform of national policies and education efforts. This study aimed to assess the status of the Korean public's knowledge towards liver-related diseases.
Materials and methods: A self-reported, cross-sectional, web-based questionnaire study was conducted between February-March 2020 among 1000 Korean adults. Questionnaire items assessed the knowledge, awareness, and behaviors towards liver-related health and diseases.
Results: About half (50.9%-52.1%) knew untreated/chronic viral hepatitis could lead to liver failure and/or cancer. Misconceptions pertaining to viral hepatitis transmission risks exist with only 26.3% knowing viral hepatitis B cannot be transmitted by dining with an infected individual. About one-fifth (22.2%) were aware of an available cure for viral hepatitis C. Less than half were aware of the risk factors associated with nonalcoholic steatohepatitis (NASH), despite 72.4% and 49.5% having heard of fatty liver disease and NASH, respectively. More than one-third were unlikely to seek medical consultation even if exposed to viral hepatitis risk factors or upon diagnosis with a liver condition. Reasons for this low urgency included costs-related concerns, perceptions of being healthy, and the viewpoint that the condition is not life-threatening.
Conclusion: The public's knowledge towards liver-related diseases in Korea was found to be lacking, which could account for a lower sense of urgency towards screening and treatment. More efforts are needed to address misperceptions and dispel stigma in an effort to encourage pro-health seeking behaviors.
Keywords: Hepatitis B; awareness; hepatitis C; knowledge; nonalcoholic fatty liver disease.
© Copyright: Yonsei University College of Medicine 2022.
Conflict of interest statement
Myunghwa Kim and Jin Youn are employees of Gilead Sciences, Korea. Shikha Singh is an employee of Kantar Health. Sang Hoon Ahn has acted as advisor and investigator for Gilead, Janssen, AbbVie, Roche, Assembly Biosciences, Arbutus, Brii, Vaccitech, GSK, Inovio, Aligos, Vir Biotechnology, SL Vaxigen, GeneOne Life Science, GreenCross, Yuhan, Samil and Ildong. Hye Won Lee declares no conflicts of interest.
Figures




Similar articles
-
Understanding the knowledge, awareness, and attitudes of the public towards liver diseases in Malaysia.Eur J Gastroenterol Hepatol. 2023 Jul 1;35(7):742-752. doi: 10.1097/MEG.0000000000002548. Epub 2023 May 8. Eur J Gastroenterol Hepatol. 2023. PMID: 37161976 Free PMC article.
-
Questionnaire survey on knowledge, attitudes, and behaviour towards viral hepatitis among the Hong Kong public.Hong Kong Med J. 2022 Feb;28(1):45-53. doi: 10.12809/hkmj219463. Epub 2021 Jul 23. Hong Kong Med J. 2022. PMID: 34294603
-
Public awareness and knowledge of liver health and diseases in Singapore.J Gastroenterol Hepatol. 2021 Aug;36(8):2292-2302. doi: 10.1111/jgh.15496. Epub 2021 Mar 30. J Gastroenterol Hepatol. 2021. PMID: 33735936 Free PMC article.
-
Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral-liver axis.Periodontol 2000. 2021 Oct;87(1):204-240. doi: 10.1111/prd.12387. Periodontol 2000. 2021. PMID: 34463983 Free PMC article. Review.
-
Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.World J Gastroenterol. 2015 Dec 14;21(46):12989-95. doi: 10.3748/wjg.v21.i46.12989. World J Gastroenterol. 2015. PMID: 26675364 Free PMC article. Review.
Cited by
-
Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients.Hepatol Int. 2024 Oct;18(Suppl 2):922-940. doi: 10.1007/s12072-024-10692-4. Epub 2024 Jul 16. Hepatol Int. 2024. PMID: 39012579 Review.
-
Parental metabolic syndrome and elevated liver transaminases are risk factors for offspring, even in children and adolescents with a normal body mass index.Front Nutr. 2023 Oct 24;10:1166244. doi: 10.3389/fnut.2023.1166244. eCollection 2023. Front Nutr. 2023. PMID: 37941769 Free PMC article.
-
Effect of Statins for Primary Prevention of Cardiovascular Disease According to the Fatty Liver Index.J Epidemiol Glob Health. 2024 Sep;14(3):710-719. doi: 10.1007/s44197-024-00205-9. Epub 2024 Feb 23. J Epidemiol Glob Health. 2024. PMID: 38393512 Free PMC article.
-
Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity.PLoS One. 2024 Aug 26;19(8):e0307712. doi: 10.1371/journal.pone.0307712. eCollection 2024. PLoS One. 2024. PMID: 39186715 Free PMC article.
-
Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma.Yonsei Med J. 2024 Jul;65(7):371-379. doi: 10.3349/ymj.2023.0263. Yonsei Med J. 2024. PMID: 38910299 Free PMC article.
References
-
- Sepanlou SG, Safiri S, Bisignano C, Ikuta KS, Merat S, Saberifiroozi M, et al. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5:245–266. - PMC - PubMed
-
- World Health Organization. Global health sector strategy on viral hepatitis, 2016–2021. [accessed on 2020 December 14]. Available at: https://apps.who.int/iris/bitstream/handle/10665/246177/WHO-HIV-2016.06-... .
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical